Background: Follicular lymphoma (FL) tumors are infiltrated with antitumor T cells, however,
their function is impaired by immune checkpoints such as PD-1/PD-ligand pathway. Blocking …

Follicular lymphoma is a usually indolent lymphoma that responds well to chemotherapy.
While multiple treatments show a good response rate, most patients relapse. Emerging …

Patients with advanced follicular lymphoma (FL) have numerous treatment options,
including observation, radiotherapy, single-agent or combination chemotherapy, mAbs, and …

BACKGROUND. It is unclear whether new treatment modalities have improved the survival
of follicular lymphoma patients. Some data show that there has been no improvement in …

High-dose chemotherapy supported by autologous stem cell transplantation (HDT/ASCT)
has contributed to modify the natural history of follicular lymphoma (FL); however, an overall …

Follicular lymphoma is usually considered as incurable, but patient's outcome has been
steadily improving over the last decade. The introduction of anti-CD20 monoclonal …

After decades of stagnation, the prognosis of patients with follicular lymphomas (FL) has
changed substantially within the last few years due to new and effective therapeutic …

Anti‐CD20 antibody in combination with chemotherapy extends overall survival (OS) in
untreated advanced‐stage follicular lymphoma (FL), yet the optimal associated therapy is …

Purpose Twenty percent of patients with follicular lymphoma (FL) experience progression of
disease (POD) within 2 years of initial chemoimmunotherapy. We analyzed data from the …

Introduction Follicular lymphoma (FL) is the most common indolent lymphoma with a median
survival approaching 20 years. However, there is significant clinical heterogeneity with a …